Lexapro

Escitalopram, the active ingredient in Lexapro, is a selective serotonin reuptake inhibitor (SSRI) presented as a tablet for oral use. It treats major depressive disorder and generalized anxiety disorder in adults.

GNH USA supplies Lexapro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lexapro (escitalopram) is an SSRI indicated for the following conditions:

- Major depressive disorder: reduces depressive symptoms and improves overall mood. - Generalized anxiety disorder: alleviates excessive worry and promotes functional improvement. - Panic disorder: decreases the frequency and severity of panic attacks.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or throbbing pain. - Insomnia: difficulty falling or staying asleep. - Dry mouth: reduced salivation. - Sexual dysfunction: decreased libido or delayed orgasm. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Serotonin syndrome: agitation, hyperthermia, muscle rigidity. - Suicidal thoughts: emergence of new or worsening ideation. - Severe allergic reaction: rash, swelling, breathing difficulty. - QT interval prolongation: cardiac rhythm disturbance. - Abnormal bleeding: easy bruising or prolonged clotting. - Hyponatremia: low blood sodium causing confusion or seizures.

Before initiating therapy, consider the following precautions: - Assess for suicidal ideation: monitor mood changes, especially early in treatment. - Monitor for serotonin syndrome: avoid concurrent serotonergic agents. - Caution in hepatic impairment: dose adjustment may be required. - Avoid abrupt discontinuation: taper under medical supervision to reduce withdrawal. - Use with caution in pregnancy: evaluate risk‑benefit with a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Escitalopram may interact with other medicines. Review the following groups:

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome. - Pimozide: can cause cardiac arrhythmias. - Thioridazine: may lead to QT prolongation.

Moderate Interactions (Monitor Closely): - NSAIDs or anticoagulants: increased bleeding risk. - Other serotonergic agents (e.g., triptans, tramadol): may elevate serotonin levels. - Carbamazepine: may reduce escitalopram plasma concentrations.